Investigation of the Effectiveness of Foot Core Exercise Training With Telerehabilitation in Individuals With Rheumatoid Arthritis: A Randomized Controlled Single-Blind Study
Foot Core Exercise Training for Rheumatoid Arthritis
Plain English Summary
Foot Core Exercise Training With Telerehabilitation is a Not Applicable clinical trial sponsored by Pamukkale University studying Rheumatoid Arthritis, Foot Core, Exercise. Tests the effectiveness of foot core exercise training with telerehabilitation for rheumatoid arthritis patients. For individuals aged 18-65 with rheumatoid arthritis, willing to participate in the study. Participation involves weekly exercise sessions via telehealth, focusing on foot and lower extremity exercises. Alternative treatments include traditional in-person physical therapy or medication. The trial aims to enroll 18 participants.
Official Summary
The aim of this study was to investigate the effects of lower extremity exercises combined with foot core exercise training on lower extremity pain, foot functionality, static and dynamic parameters of gait, and postural stability in individuals with rheumatoid arthritis using synchronous and asynchronous telerehabilitation methods.
Who Can Participate
Here is what you need to know about eligibility for this trial. Can join if diagnosed with rheumatoid arthritis, between 18-65 years old, and willing to participate. Cannot join if have a neurological disease, pulmonary or cardiovascular issues, sensory system disorders, or a history of lower extremity or trunk surgery. Age range is 18-65 years. Health requirements include no neurological, pulmonary, cardiovascular, or sensory system disorders, and no history of lower extremity or trunk surgery. This trial is studying Rheumatoid Arthritis, Foot Core, Exercise, so participants generally need a confirmed diagnosis.
What They're Measuring
The primary outcome measures will show improvements in foot posture, gait, and postural stability, which can help reduce pain and improve mobility for patients. The specific primary outcome measures are: Foot Posture Index (Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period.); Static Gait Analysis Evaluation (Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period.); Dynamic Gait Analysis Evaluation (Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period.); Postural Stability Assessment (Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period.). These endpoints are how researchers determine whether the treatment is effective and will form the basis of any future regulatory submissions.
About This Phase
This study does not have a traditional clinical phase designation. It may be an observational study that follows patients without intervening in their care, an expanded access or compassionate use program, or other non-interventional research. These studies contribute valuable data about disease progression, treatment patterns, and patient outcomes.
Why This Trial Matters
This trial aims to fill the gap in treatment options for rheumatoid arthritis by focusing on foot core exercise training through telehealth. This research targets Rheumatoid Arthritis, Foot Core, Exercise, where improved treatment options are needed.
Investor Insight
The market size for rheumatoid arthritis treatments is significant, with a competitive landscape that includes various therapies. The approval probability is moderate given the promising nature of the
Is This Trial Right for Me?
Ask your doctor if you have any neurological, pulmonary, or cardiovascular issues that might affect your participation. Participation involves weekly exercise sessions via telehealth, focusing on foot and lower extremity exercises. The trial is being conducted at 1 site. Always discuss clinical trial participation with your healthcare provider before making any decisions. This information is for educational purposes only and is not medical advice.
AI-generated analysis for educational purposes only. This is not medical advice. Discuss clinical trial participation with your doctor. Data sourced from ClinicalTrials.gov.
Study Design
- Study Type: INTERVENTIONAL
- Allocation: RANDOMIZED
- Model: PARALLEL
- Masking: SINGLE
- Enrollment: 18 participants
Interventions
- OTHER: Asynchronous exercise group — Application of foot core training combined with lower extremity exercises using asynchronous telerehabilitation method.
- OTHER: Synchronous exercise group — Application of foot core training combined with lower extremity exercises using synchronous telerehabilitation method.
Primary Outcomes
- Foot Posture Index (Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period.)
- Static Gait Analysis Evaluation (Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period.)
- Dynamic Gait Analysis Evaluation (Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period.)
- Postural Stability Assessment (Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period.)
Secondary Outcomes
- Visual Analog Scale-Pain (Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period.)
- Foot Function Index (Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period.)
Full Eligibility Criteria
Inclusion Criteria: * Having been diagnosed with rheumatoid arthritis * Being between the ages of 18-65 * Being willing to participate in the study Exclusion Criteria: * Having a neurological disease * Having a pulmonary or cardiovascular problem that may affect daily life activities * Sensory system disorders * Having a history of surgery on the lower extremities or trunk * Experiencing dizziness * Having a cognitive disorder * Having an additional rheumatic disease
Trial Locations
- Pamukkale University, Denizli, Turkey (Türkiye)
Frequently Asked Questions
What is clinical trial NCT06667856?
NCT06667856 is a Not Applicable INTERVENTIONAL study titled "Foot Core Exercise Training With Telerehabilitation." It is currently suspended and is sponsored by Pamukkale University. The trial targets enrollment of 18 participants.
What conditions does NCT06667856 study?
This trial investigates treatments for Rheumatoid Arthritis, Foot Core, Exercise. The primary condition under study is Rheumatoid Arthritis.
What treatments are being tested in NCT06667856?
The interventions being studied include: Asynchronous exercise group (OTHER), Synchronous exercise group (OTHER). Application of foot core training combined with lower extremity exercises using asynchronous telerehabilitation method.
What does Not Applicable mean for NCT06667856?
This study does not have a defined clinical phase. It may be an observational study, expanded access program, or other non-interventional research.
What is the current status of NCT06667856?
This trial is currently "Suspended." It started on 2026-09-24. The estimated completion date is 2027-07-24.
Who is sponsoring NCT06667856?
NCT06667856 is sponsored by Pamukkale University. The sponsor is responsible for funding, designing, and overseeing the clinical trial.
How many people can participate in NCT06667856?
The trial aims to enroll 18 participants. The trial status is suspended.
How is NCT06667856 designed?
This is a interventional study, uses randomized allocation, follows a parallel design, employs single masking. Masking means some participants and/or investigators do not know which treatment group a participant is in, which helps reduce bias.
What are the primary outcomes being measured in NCT06667856?
The primary outcome measures are: Foot Posture Index (Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period.); Static Gait Analysis Evaluation (Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period.); Dynamic Gait Analysis Evaluation (Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period.); Postural Stability Assessment (Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period.). These are the main endpoints researchers use to determine whether the treatment is effective.
Where is NCT06667856 being conducted?
This trial is being conducted at 1 site, including Denizli (Turkey (Türkiye)).
Where can I find official information about NCT06667856?
The official record for NCT06667856 is available on ClinicalTrials.gov at https://clinicaltrials.gov/study/NCT06667856. This government database provides the most up-to-date and detailed information about the trial.
What is NCT06667856 testing in simple terms?
Tests the effectiveness of foot core exercise training with telerehabilitation for rheumatoid arthritis patients. For individuals aged 18-65 with rheumatoid arthritis, willing to participate in the study.
Why is this trial significant?
This trial aims to fill the gap in treatment options for rheumatoid arthritis by focusing on foot core exercise training through telehealth.
What are the potential risks of participating in NCT06667856?
Key risks include potential discomfort during exercise sessions, but these are generally manageable. Side effects are minimal, but participants should report any unusual symptoms to their healthcare provider. As with any clinical trial, participants are closely monitored and can withdraw at any time.
Should I consider participating in NCT06667856?
Ask your doctor if you have any neurological, pulmonary, or cardiovascular issues that might affect your participation. Participation involves weekly exercise sessions via telehealth, focusing on foot and lower extremity exercises. Always discuss clinical trial participation with your healthcare provider to determine if it is appropriate for your specific situation.
What does NCT06667856 signal from an investment perspective?
The market size for rheumatoid arthritis treatments is significant, with a competitive landscape that includes various therapies. The approval probability is moderate given the promising nature of the This is a Not Applicable trial, which is in early development stages.
What happens if the treatment in this trial doesn't work?
Participation involves weekly exercise sessions via telehealth, focusing on foot and lower extremity exercises. Participants in clinical trials always have the right to withdraw and pursue alternative treatments. The study team will help transition patients to other available options.
Related Conditions
More Rheumatoid Arthritis Trials
This analysis is AI-generated and does not constitute medical advice. Always consult your healthcare provider before making decisions about clinical trial participation.